A recent study indicated that inhibiting the expression of Ezrin limited morphological changes and actin filament remodelling, thereby reducing the migration and invasion of cells during EMT.35 Here we demonstrated that when Ezrin was silenced, BC cells attained an epithelial morphology and lost their migratory capability. The gene discussed is EZR; the disease is breast cancer.